Detalhe da pesquisa
1.
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors.
Breast Cancer Res
; 25(1): 51, 2023 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147730